We are live on
!
Find out more
VC
VarCov Co Portfolio holdings
AUM
$263M
This Fund
S&P 500
This Quarter
Est. Return
+0.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$253M
AUM Growth
–
Cap. Flow
+$258M
Cap. Flow
% of AUM
101.98%
Top 10 Holdings %
Top 10 Hldgs %
10.78%
Holding
436
New
436
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Industrial Realty Trust
FR
|
+$4.41M |
| 2 |
Chevron
CVX
|
+$3.82M |
| 3 |
Coursera
COUR
|
+$3.49M |
| 4 |
C3.ai
AI
|
+$2.85M |
| 5 |
Phillips Edison & Co
PECO
|
+$2.56M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.9% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 13.67% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Industrials | 13.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Ardelyx
ARDX
$873M
| $262K | 0.1% |
+45,004
| New | +$251K |
2025 Q4
0 quarters
|
|
327
Spyre Therapeutics
SYRE
$8.15B
| $262K | 0.1% |
+8,008
| New | +$209K |
2025 Q4
0 quarters
|
|
328
Oric Pharmaceuticals
ORIC
$1.28B
| $262K | 0.1% |
+32,036
| New | +$369K |
2025 Q4
0 quarters
|
|
329
MeiraGTx Holdings
MGTX
$1.05B
| $262K | 0.1% |
+32,945
| New | +$274K |
2025 Q4
0 quarters
|
|
330
Intellia Therapeutics
NTLA
$1.73B
| $262K | 0.1% |
+29,109
| New | +$401K |
2025 Q4
0 quarters
|
|
|
FLY
331
Firefly Aerospace
FLY
$3.7B
| $262K | 0.1% |
+11,697
| New | +$271K |
2025 Q4
0 quarters
|
|
332
Tango Therapeutics
TNGX
$3.83B
| $261K | 0.1% |
+29,486
| New | +$254K |
2025 Q4
0 quarters
|
|
|
UPB
333
Upstream Bio Inc
UPB
$262M
| $261K | 0.1% |
+9,619
| New | +$239K |
2025 Q4
0 quarters
|
|
|
DAWN
334
DELISTED
Day One Biopharmaceuticals
DAWN
| $261K | 0.1% |
+28,016
| New | +$234K |
2025 Q4
0 quarters
|
|
335
Uranium Energy
UEC
$4.69B
| $261K | 0.1% |
+22,339
| New | +$293K |
2025 Q4
0 quarters
|
|
336
Keros Therapeutics
KROS
$225M
| $261K | 0.1% |
+12,810
| New | +$225K |
2025 Q4
0 quarters
|
|
337
Verastem
VSTM
$719M
| $261K | 0.1% |
+33,775
| New | +$301K |
2025 Q4
0 quarters
|
|
338
FuboTV Inc
FUBO
$258M
| $261K | 0.1% |
+8,622
| New | +$344K |
2025 Q4
0 quarters
|
|
339
Nasdaq
NDAQ
$51.2B
| $260K | 0.1% |
+2,681
| New | +$241K |
2025 Q4
0 quarters
|
|
340
Travere Therapeutics
TVTX
$5.42B
| $260K | 0.1% |
+6,814
| New | +$222K |
2025 Q4
0 quarters
|
|
341
Flex
FLEX
$43.4B
| $260K | 0.1% |
+4,307
| New | +$266K |
2025 Q4
0 quarters
|
|
342
Gossamer Bio
GOSS
$62.9M
| $260K | 0.1% |
+1,048
| New | +$239K |
2025 Q4
0 quarters
|
|
343
ARS Pharmaceuticals
SPRY
$423M
| $260K | 0.1% |
+22,300
| New | +$217K |
2025 Q4
0 quarters
|
|
|
KBDC
344
Kayne Anderson BDC
KBDC
$843M
| $259K | 0.1% |
+18,104
| New | +$264K |
2025 Q4
0 quarters
|
|
345
BorgWarner
BWA
$12.3B
| $259K | 0.1% |
+5,742
| New | +$252K |
2025 Q4
0 quarters
|
|
346
Zymeworks
ZYME
$1.9B
| $259K | 0.1% |
+9,818
| New | +$214K |
2025 Q4
0 quarters
|
|
347
Green Dot
GDOT
$712M
| $258K | 0.1% |
+20,162
| New | +$250K |
2025 Q4
0 quarters
|
|
|
GRAL
348
GRAIL Inc
GRAL
$6.67B
| $258K | 0.1% |
+3,017
| New | +$261K |
2025 Q4
0 quarters
|
|
349
Richtech Robotics
RR
$392M
| $257K | 0.1% |
+79,528
| New | +$352K |
2025 Q4
0 quarters
|
|
350
Nucor
NUE
$57.2B
| $257K | 0.1% |
+1,573
| New | +$236K |
2025 Q4
0 quarters
|
|
Similar funds
IAG
GC
HWMC
KAM
GSB
AIA
GF
NWA
VarCov Co's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for VarCov Co, which disclosed 436 positions worth $253M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is First Industrial Realty Trust: 78,970 shares worth $4.52M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, followed by Healthcare and Financials.
- VarCov Co's largest Q4 2025 buy was First Industrial Realty Trust: 78,970 shares worth $4.52M.
- VarCov Co's ten largest holdings make up 11% of its $253M portfolio in Q4 2025.
- VarCov Co disclosed 436 positions in Q4 2025, its first 13F filing on record.
Based on VarCov Co's 13F filing for Q4 2025, filed 17 Feb 2026.